Post-operative Pain Management Market : 2020 | size| Share | Report and Growth Factors

 Post-operative Pain Management Market Analysis 

The global post-operative pain management market is predicted to grow at a 5.4% CAGR between 2017-2023, reveals the latest Market Research Future (MRFR) report. Post-operative pain is unpleasant and annoying, which, if not treated correctly and on time, can result in chronic pain, which may last for months. Post-operative pain is a common adverse outcome owing to physical distress, prolonged hospital stays, and the growing incidence of readmissions of patients after surgery. Post-operative pain management helps in minimizing patient discomfort, facilitating early mobilization, functional recovery along with preventing acute pain turning into chronic pain. Besides, it also helps to lessen the possibility of pulmonary, cardiac, and neuropathic pain complications, low cost of care, and cut down the risk of thrombosis. 

Get Latest Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/1246

Various factors are propelling the post-operative pain management market growth. These factors, as per the new Market Research Future (MRFR) report, include growing incidence of diseases that need surgical treatments, development of novel drugs for quick pain relief, increased R&D activities to develop high-quality post-operative pain management solutions with minimum side effects, increasing prevalence of various chronic diseases such as cardiovascular diseases, renal diseases, cancer, and others, and increase in geriatric population. Additional factors pushing market growth include the increasing number of cancer patients and burgeoning demand for pain control devices and drugs. 

On the flip side, poor primary health care services, especially in underdeveloped regions and complications related to overdose of pain management drugs, are factors that may impede the post-operative pain management market growth over the forecast period. 

Market Segmentation

The MRFR report provides an all-inclusive segmental analysis of the Post Operative Pain Management Market Growth on the basis of target area, application, product, and pain type. 

Based on pain type, the post-operative pain management market is segmented into severe pain, moderate pain, and acute pain. 

Based on the product, the post-operative pain management market is segmented into opioids, COX-2 inhibitors, antiepileptic drugs, non-steroidal anti-inflammatory drugs, and other analgesics. 

Based on the application, the post-operative pain management market is segmented into migraine, musculoskeletal pain, neuropathic pain, arthritic pain, cancer pain, and others. Of these, the cancer pain segment will have the largest share in the market over the forecast period. 

Based on target area, the global post-operative pain management market is segmented into arms, hand, legs, back, and others.

Regional Analysis

By region, the post-operative pain management market report covers the latest trends and growth opportunities across the Asia Pacific (APAC), the Americas, Europe, and the Middle East and Africa. Of these, the Americas will dominate the market over the forecast period. This is chiefly on account of the presence of well-developed healthcare infrastructure in the region and the huge patient pool undergoing surgical procedures. 

The post-operative pain management market in Europe is predicted to have the second-largest share in the market over the forecast period. This is chiefly on account of the increasing R&D activities for the launch of new drugs with minimal side-effects. 

The post-operative pain management market in the APAC region is predicted to grow at the fastest pace over the forecast period. This is chiefly on account of the growing incidence of chronic diseases that needs surgical treatment coupled with an increase in the geriatric population. 

The global post-operative pain management market in the MEA is predicted to have steady growth over the forecast period. This is chiefly on account of poor primary health care services, especially in the region’s underdeveloped areas and lack of awareness. 

Key Players

Prominent players profiled in the post-operative pain management market report include Valeant Pharmaceuticals International Inc. (Canada), Baxter International Inc. (the US), F. Hoffmann-La Roche Ltd. (Switzerland), GlaxoSmithKline Plc. (the UK), Forest Laboratories Inc. (the US), Endo Pharmaceuticals Plc. (the US), Purdue Pharma (the US), Johnson & Johnson (the US), Pfizer (the US), Eli Lilly (the US), and Teva Pharmaceutical Industries Ltd. (Israel). Key players have incorporated several strategies to create a niche in the market, such as research and development activities, joint ventures, expansions, product launches, and more. 

Industry News

August 2019: Dr. Reddy’s Laboratories has recently launched generic anti-epileptic Vigabatrin powder in the US market for oral solution. 

Read more @ https://www.marketresearchfuture.com/reports/post-operative-pain-management-market-1246

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Post-operative Pain Management Market By Technology Advancement, Growth and Forecasts 2023

Post-operative Pain Management Market- Overview:

Patient’s comfort is of the utmost priority in the healthcare sector, and post-operative pain management has a significant role to play in it. Pain is an unavoidable result in a post-operative scenario due to tissue injury and muscle spasm which can be treated with proper medication. The global post-operative pain management market is thriving on this. With an intent to mobilize the patient at the earliest and resume their ability to breathe and eat, physicians introduce these post-operative drugs. The demand for drugs and devices to treat such cases are on the rise as healthcare is now permeating to a wider patient pool. This has increased the number of surgeries where the requirement for such devices is obvious.

Furthermore, age becomes a complication as the reception of drugs in such cases differ from any normal patients which opens up scope for new drugs and researches. The global post-operative pain management market is set to grow with 5.4% CAGR during the forecast period (2017-2023), reveals Market Research Future (MRFR). The report has its finger on segmental analysis and factors that can be of great importance for the market in the coming years.  

On the flipside, these drugs often become a habit and overdose of it can cause fatal damage. This can be a daunting threat to the post-operative pain management market. As per the Centre for Disease Control and Prevention, the last decade has already witnessed a steep rise in the number of deaths caused by such overdoses.

Post-operative Pain Management Market Segmentation:

The global post-operative pain management market can be segmented by pain type, product, application, and target area.

Based on the pain type, the post-operative pain management market can be segmented into acute pain, moderate pain, and severe pain.

On the basis of product, the post-operative pain management market includes non-steroidal anti-inflammatory drugs (NSAIDs), antiepileptic drugs, COX-2 inhibitors, opioids, and other analgesics.

Application-wise, the post-operative pain management market comprises cancer pain, arthritic pain, neuropathic pain, musculoskeletal pain, migraine, and others.

Based on target area, the post-operative pain management market comprises back, legs, hand, arms and other.

Post-operative Pain Management Market Regional Analysis:

Geographically, the global post-operative pain management market includes the Americas, Europe, Asia Pacific (APAC) and the Middle East & Africa (MEA).

The Americas is having a great run in the global post-operative pain management market due to the large patient pool availing treatment and surgical procedures. Superlative healthcare infrastructure is also impacting the market significantly in this region.

Europe accounts for the second largest revenue share owing to the increasing research and development (R&D) activities for the introduction of new drugs with fewer side-effects. Both private and public sectors are investing significant sums for R & D which is pushing the market forward.

The APAC is set for the fastest growth during the forecast period. The huge patient pool is expected to provide traction to the market. The post-operative pain management market in the MEA is projecting steady growth. However, lack of awareness and poor primary health care services in the underdeveloped areas of this region are posing great threats to the market.

Competitive Analysis:

The prominent players profiled in the global post-operative pain management market are Johnson & Johnson (the U.S.), Purdue Pharma (the U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Pfizer (the U.S.), Eli Lilly (the U.S.),  Endo Pharmaceuticals Plc. (the U.S.), Forest Laboratories Inc. (the U.S.), GlaxoSmithKline Plc. (the U.K.), Baxter International Inc. (the U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Valeant Pharmaceuticals International Inc. (Canada), and others.

In August 2018, a panel of expert researchers from the John Hopkins University, a private American university, have declared operation-specific prescribing guidelines for 20 common surgical procedures.

In October 2018, the American Society of Anesthesiologists published a report that talked about a new form of anesthesia used during the treatment of breast cancer. The new procedure is a regional anesthesia technique that includes treatment by injecting long-acting anesthetics, directed by ultrasound, to numb the front part of the chest wall.  

Read More @ https://www.marketresearchfuture.com/reports/post-operative-pain-management-market-1246